The heavy scrutiny by Congress, payers, and the media on drug price hikes may be having its intended impact – giving manufacturers pause with respect to the frequency and/or magnitude of price increases. There’s another effect that bears keeping in mind, on the wholesalers that have long operated with a margin-dependent business model that factors price increases into revenue projections
Read More